What is STI Pharma?
Founded in 2008 and based in Newtown, PA, STI Pharma is a specialty pharmaceutical firm. The company's core strategy revolves around the acquisition, development, and marketing of high-quality pharmaceutical products. STI Pharma places a particular strategic emphasis on the oncology and injectables therapeutic areas, aiming to address critical unmet needs within these markets.
How much funding has STI Pharma raised?
STI Pharma has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in STI Pharma
PPP
Public-Private Partnership
What's next for STI Pharma?
The substantial late-stage funding positions STI Pharma for accelerated growth and market penetration. This capital infusion is expected to fuel further development of its product pipeline, enhance its marketing and sales infrastructure, and potentially support strategic acquisitions. The company's focus on oncology and injectables aligns with high-demand sectors within the pharmaceutical industry, suggesting a trajectory towards significant commercialization and expansion.
See full STI Pharma company page